🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 18% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

37.3 Gram(s) Serving Size
24 Servings
Other Combinations Product Type
18% Evidence Coverage

Supplement Facts — Evidence Check

Calories
140 Calorie(s)
Total Fat
3 Gram(s) (4% DV)
Cholesterol
40 mg (13% DV)
Total Carbohydrate
2 Gram(s) (1% DV)
Protein
25 Gram(s) (50% DV)
Calcium
273 mg (21% DV)
Iron
1.95 mg (11% DV)
137 mg (11% DV)
✅ Within RDA (0.2× RDA of 700 mg) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 137mg UL 4000mg
47 mg (11% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 47mg
Sodium
137 mg (6% DV)
Potassium
332 mg (7% DV)

Other Ingredients

Cocoa powder Coconut Oil Creamer Natural & Artificial flavors Gum Acacia Cellulose Gum Xanthan Gum Guar Gum Carrageenan Sodium Chloride Sucralose DigeSEB Sunflower Lecithin

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (98% of products) Structure/Function (89% of products) Nutrient (76% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Directions: Add 1 scoop to 6-8 ounces of cold water and shake or stir until mixed.

⚠️ Warnings & Precautions

Warning: Consuming this product can expose you to chemicals including lead, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

Warning: This product is only intended for use in healthy adults 18 years of age or older. Keep out of reach of children.

Pregnant or nursing women should not use this product. Consult your healthcare provider before using this product, especially if you are taking any prescription, over the counter medication, dietary supplement product, or if you have any pre-existing medical condition including but not limited to: high or low blood pressure, cardiac arrhythmia, stroke, heart, liver, kidney or thyroid disease, seizure disorder, psychiatric disease, diabetes, difficulty urinating due to prostate enlargement or if you are taking a MAOI (Monoamine Oxidase Inhibitor) or any other medication.

Immediately discontinue use and consult your health care professional if you experience adverse reaction to this product. Do not exceed recommended serving. Do not use if safety seal is broken or missing.

Allergen Information: Contains milk and coconut. Manufactured in a facility which processes milk, egg, fish, shellfish, tree nuts, peanuts, wheat, and soybeans.

🧪 Formulation Notes

Core Nutritionals Core PRO is no different. As an innovative, clinical-strength, and sustained-released protein formula, Core PRO provides your body the fuel it needs, when it needs it. Comprised of an advanced mixture of fast-uptake and sustained-release proteins, our non-proprietary blend of protein sources optimizes your growth and recovery with a targeted approach to protein kinetics, synthesis, and metabolism. Further enhanced by a powerful digestive enzyme blend and an amino ratio clinically-verified as superior, Core PRO is metabolically-complete growth solution. At the same time, Core PRO does not sacrifice taste for quality. With gourmet flavors that are second to none and a silky-smooth texture, Core PRO is the best tasting, highest quality protein supplement available.

Manufactured in a U.S. cGMP facility.

Sustained release protein blend Full disclosure whey/casein blend Complete amino acid profile Death By Chocolate Naturally & Artificially Flavored

No fillers

Additional Information

At Core Nutritionals, efficiency is a philosophy and guiding principle - something we put into everything we do as a company because it's important to everything you do as an athlete.

Protect from heat, light and moisture. Store at 10-25 Degrees C (50-77 Degrees F)

Gourmet taste Typical Amino Acid Profile Amount per serving Alanine 1097 mg Arginine 681 mg Aspartic Acid 2370 mg Cysteine 467 mg Glutamic Acid 4309 mg Glycine 445 mg Histidine 513 mg Isoleucine 1453 mg Leucine 2628 mg Lysine 2235 mg Methionine 586 mg Phenylalanine 880 mg Proline 1832 mg Serine 1287 mg Threonine 1498 mg Tryptophan 414 mg Tyrosine 865 mg Valine 1481 mg Total 25,041 mg Essential Amino Acids BCAA's The L-Tryptophan indicated is from naturally occurring sources of protein.

Product Details

UPC / SKU 6 72975 00978 6
DSLD Entry Date 2023-10-24
Product Type Other Combinations
Form Powder
DSLD ID 298268
Data Updated 2026-04-11

Research Evidence

46 Research Sources
55 Avg Quality Score
23 Meta Analysis
7 Systematic Review
7 Rct
4 Clinical Trial
2 Other
1 Guideline
1 Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024
View all evidence for Phosphorus →

Compare Similar Products

View all Phosphorus products →